Ebixa is well tolerated

The overall frequency of patients who experienced side-effects was similar with Ebixa compared to placebo.

Read more...

Ebixa - Efficacy in Alzheimer's disease

In clinical studies, Ebixa has shown to be an efficacious treatment compared with placebo for moderate to severe Alzheimer's disease.

Read more...

Ebixa® - The treatment approved for moderate to severe Alzheimer's Disease

Want to know more about Ebixa?

Ebixa is a specific, uncompetitive NMDA-receptor antagonist, and has a novel mechanism of action for the treatment of patients with moderate to severe Alzheimer’s Disease.

Prescribing information

The Prescribing Information outlines the indications of the product, as well as specifics such as dosage, contra-indications, pregnancy and lactation, precautions, drug interactions, adverse events and overdoses.

Read more...